نتائج البحث

1

Surgical Resection After Talimogene Laherparepvec for Melanoma: Persistent Fuorodeoxyglucose Avidity on Positron Emission Tomography Despite No Viable Disease

المؤلفون: Taleen A. MacArthur, Aodhnait S. Fahy, James W. Jakub

المصدر: Am Surg

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Skin Neoplasms, Minnesota, Herpesvirus 1, Human, Injections, Intralesional, Article, 030207 dermatology & venereal diseases, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Fluorodeoxyglucose F18, Surgical oncology, medicine, Humans, Melanoma, Pathological, Aged, Retrospective Studies, Ultrasonography, Fluorodeoxyglucose, Biological Products, medicine.diagnostic_test, business.industry, General Medicine, Middle Aged, medicine.disease, Institutional review board, Combined Modality Therapy, Oncolytic virus, Positron emission tomography, Positron-Emission Tomography, 030220 oncology & carcinogenesis, Radiology, Radiopharmaceuticals, business, Talimogene laherparepvec, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd00bea70abd7699ee5efae05f43832Test
https://doi.org/10.1177/00031348211023434Test

2

FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression

المؤلفون: Hu Huang, Mingjie Zhu, Xiaofeng Dai, Junqiang Wu, Qing Lv, Shiming Guan

المصدر: Technology in Cancer Research & Treatment
Technology in Cancer Research & Treatment, Vol 20 (2021)

مصطلحات موضوعية: Adult, Cancer Research, Antineoplastic Agents, Hormonal, Cell Survival, Estrogen receptor, Breast Neoplasms, Disease, Kaplan-Meier Estimate, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, breast cancer, medicine, Humans, Receptor, Fibroblast Growth Factor, Type 1, skin and connective tissue diseases, 030304 developmental biology, Cell Proliferation, Proportional Hazards Models, 0303 health sciences, Proportional hazards model, Cell growth, business.industry, Fibroblast growth factor receptor 1, Estrogen Receptor alpha, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Prognosis, Survival Rate, stomatognathic diseases, Tamoxifen, FGFR1, tamoxifen resistant, Oncology, ER, Receptors, Estrogen, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Gene Knockdown Techniques, Cancer research, MCF-7 Cells, Immunohistochemistry, Original Article, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fd93d507d55afe0a89f83ad219ace96Test
http://europepmc.org/articles/PMC8013883Test

3

Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy: A randomised, double-blind, placebo-controlled trial

المؤلفون: Anne-Marie Langmach Wegeberg, Poul Erik Jakobsen, Adam D. Farmer, Jesper Karmisholt, Birgitte Brock, Asbjørn Mohr Drewes, Christian Stevns Hansen, Christina Brock

المصدر: United European Gastroenterol J
Wegeberg, A-M L, Hansen, C S, Farmer, A D, Karmisholt, J S, Drewes, A M, Jakobsen, P E, Brock, B & Brock, C 2020, ' Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy : A randomised, double-blind, placebo-controlled trial ', United European Gastroenterology Journal, vol. 8, no. 6, pp. 695-704 . https://doi.org/10.1177/2050640620925968Test
Wegeberg, A M L, Hansen, C S, Farmer, A D, Karmisholt, J S, Drewes, A M, Jakobsen, P E, Brock, B & Brock, C 2020, ' Liraglutide accelerates colonic transit in people with type 1 diabetes and polyneuropathy : A randomised, double-blind, placebo-controlled trial ', United European Gastroenterology Journal, vol. 8, no. 6, pp. 695-704 . https://doi.org/10.1177/2050640620925968Test

مصطلحات موضوعية: Male, Placebo-controlled study, Appetite, Gastroenterology, gastrointestinal motility, Enteric Nervous System, Placebos, 0302 clinical medicine, Diabetes mellitus type 1, Weight loss, Intestine, Small, Medicine, Diabetic Nephropathies, Prospective Studies, liraglutide, digestive, oral, and skin physiology, Stomach, Nausea, Middle Aged, Postprandial Period, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, polyneuropathies, 030211 gastroenterology & hepatology, Female, medicine.symptom, Polyneuropathy, medicine.drug, Adult, medicine.medical_specialty, Glucagon-Like Peptide-1 Receptor, Double blind, 03 medical and health sciences, Polyneuropathies, Double-Blind Method, Diabetes mellitus, Internal medicine, Humans, gastrointestinal transit, Adverse effect, Gastrointestinal Transit, Type 1 diabetes, business.industry, Liraglutide, Original Articles, medicine.disease, digestive signs and symptoms, Diabetes Mellitus, Type 1, Gastric Emptying, business